Related Experiment Video
Updated: Mar 18, 2026

12:24
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
12.8K
Coagulation Factor XIIIA Subunit Missense Mutations Affect Structure and Function at the Various Steps of Factor XIII
Anne Thomas1, Arijit Biswas2, Johannes Dodt3
1Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Human Mutation
|July 2, 2016
Summary
Mild Factor XIII (FXIII) deficiency, often asymptomatic, results from heterozygous mutations. This study characterizes 16 F13A1 gene mutations, revealing their impact on FXIII function and identifying those with significant heterozygous effects.
Area of Science:
- Hematology
- Molecular Genetics
- Biochemistry
Background:
- Inherited Factor XIII (FXIII) deficiency presents as severe or mild forms, influenced by genotype and phenotype.
- Mild FXIII deficiency, often heterozygous, is typically asymptomatic unless trauma occurs.
- Many mild FXIII deficiency mutations lack comprehensive characterization via expression studies.
Purpose of the Study:
- To characterize the expression phenotype of 16 previously reported missense mutations in the F13A1 gene associated with mild FXIII deficiency.
- To functionally categorize these mutations based on their impact on FXIII protein expression and function.
- To correlate in vitro findings with in silico analyses for a deeper understanding of mutation effects.
Main Methods:
- Transient expression of 16 F13A1 missense mutations.
- Analysis of expression phenotype using various determination assays.
- In silico analysis to complement in vitro expression data.
Main Results:
- Identified distinct expression phenotypes for the analyzed mutations, indicating varied impacts on FXIII function.
- Demonstrated that mutations can influence different functional aspects of the FXIII protein.
- Highlighted specific mutations (p.Arg716Gly, p.Arg704Gln, p.Gln602Lys, p.Leu530Pro, p.His343Tyr, p.Pro290Arg, p.Arg172Gln) with substantial effects even in heterozygous states.
Conclusions:
- The expression phenotype provides a functional categorization for F13A1 mutations causing mild FXIII deficiency.
- Several heterozygous mutations significantly impair FXIII protein function, necessitating further clinical correlation.
- Comprehensive characterization of mild FXIII deficiency mutations is crucial for understanding their clinical relevance.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
14.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
14.9K
Coagulation
11.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.7K
Coagulation
1.6K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Mutations
95.8K
Overview
95.8K
Mutations
45.3K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.3K

